Willow Biosciences (TSE:WLLW) Shares Down 12.5% – Time to Sell?

Willow Biosciences Inc. (TSE:WLLWGet Free Report)’s stock price dropped 12.5% on Saturday . The stock traded as low as C$0.03 and last traded at C$0.04. Approximately 1,087,062 shares changed hands during trading, an increase of 58% from the average daily volume of 685,866 shares. The stock had previously closed at C$0.04.

Willow Biosciences Price Performance

The firm has a market cap of C$5.07 million, a PE ratio of -0.64 and a beta of 1.13. The firm’s fifty day simple moving average is C$0.02 and its two-hundred day simple moving average is C$0.05. The company has a quick ratio of 19.71, a current ratio of 0.80 and a debt-to-equity ratio of 902.05.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Featured Stories

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.